RxDoctor Payments Data

Kenneth Steibel, MD

Family Medicine · Fenton, MINPI 1144398934

Payments from drug & device makers

$7,872in general payments, 2019–2025

Across 535 payments — averaging $14.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Pfizer$933
  • Novo Nordisk$771
  • Lilly USA, LLC$599
  • AstraZeneca$485
  • Amgen$337
  • plus $4K from 49 others

What the payments were for

  • Food & beverage$7,872100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$7,872 in reported general payments places this provider in the 95th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$47,144
Medicare patients
173
Services billed
1,003

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban103$120,000
MounjaroTirzepatide45$59,473
JardianceEmpagliflozin34$34,558
JanuviaSitagliptin Phosphate20$27,728
OzempicSemaglutide16$24,473
XareltoRivaroxaban15$23,282
Trelegy ElliptaFluticasone/Umeclidin/Vilanter23$16,148
FarxigaDapagliflozin Propanediol11$15,965
MyrbetriqMirabegron19$14,271
Atorvastatin Calcium421$7,886
Lantus SolostarInsulin Glargine,hum.Rec.Anlog25$5,212
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate11$4,970
Lisinopril353$4,162
Qvar RedihalerBeclomethasone Dipropionate14$3,897
Levothyroxine Sodium261$3,743

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$933$120,000103 claims
Lilly USA, LLCMounjaro$599$59,47345 claims
Boehringer IngelheimJardiance$131$34,55834 claims
MerckJanuvia$139$27,72820 claims
Novo NordiskOzempic$771$24,47316 claims
Johnson & JohnsonXarelto$13$23,28215 claims
GSKTrelegy Ellipta$317$16,14823 claims
AstraZenecaFarxiga$485$15,96511 claims
Astellas Pharma US IncMyrbetriq$210$14,27119 claims
Teva Pharmaceuticals USA, Inc.Qvar Redihaler$85$3,89714 claims
AbbVieSynthroid$1,132$2,19422 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Fenton

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →